RNA-Based Vaccines in Cancer Immunotherapy
RNA vaccines traditionally consist of messenger RNA synthesized by in vitro transcription using a bacteriophage RNA polymerase and template DNA that encodes the antigen(s) of interest. Once administered and internalized by host cells, the mRNA transcripts are translated directly in the cytoplasm and...
Saved in:
| Main Authors: | Megan A. McNamara, Smita K. Nair, Eda K. Holl |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2015/794528 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Circular RNA vaccines: Pioneering the next-gen cancer immunotherapy
by: Uddalak Das, et al.
Published: (2025-07-01) -
Emerging prospects of mRNA cancer vaccines: mechanisms, formulations, and challenges in cancer immunotherapy
by: Umm E. Laila, et al.
Published: (2024-11-01) -
mRNA vaccines and SiRNAs targeting cancer immunotherapy: challenges and opportunities
by: Zhen Lv, et al.
Published: (2025-07-01) -
Computational biology and artificial intelligence in mRNA vaccine design for cancer immunotherapy
by: Saber Imani, et al.
Published: (2025-01-01) -
Emerging Immunotherapies in Lung Cancer: The Latest Advances and the Future of mRNA Vaccines
by: Raquel Ramos, et al.
Published: (2025-04-01)